| News | Events |
| Publications | Companies |
| Clinical Trials |
Monthly Archives: May 2005
-
Contine Reading & Discuss→
-
First of a new class of LNA-based anti-cancer drugs to enter the clinic Copenhagen, 19th May 2005 Santaris Pharma, the Danish biopharmaceutical company developing gene-targeting drugs for the treatment of cancer, today announced that, having recently received regulatory approval, it is initiating a multi-centre, international Phase I/II study of SPC2996... Contine Reading & Discuss→Santaris Pharma initiates Phase I/II multi-centre clinical trial in Chronic Lymphocytic Leukaemia
0 Replies

